-
1
-
-
0034676455
-
Surfing the p53 network
-
Vogelstein B, Lane D, Levine AJ: Surfing the p53 network. Nature 408(6810), 307-310 (2000).
-
(2000)
Nature
, vol.408
, Issue.6810
, pp. 307-310
-
-
Vogelstein, B.1
Lane, D.2
Levine, A.J.3
-
2
-
-
0036674617
-
Live or let die: The cell's response to p53
-
DOI 10.1038/nrc864
-
Vousden KH, Lu X: Live or let die: The cell's response to p53. Nat. Rev. Cancer 2(8), 594-604 (2002). (Pubitemid 37328926)
-
(2002)
Nature Reviews Cancer
, vol.2
, Issue.8
, pp. 594-604
-
-
Vousden, K.H.1
Lu, X.2
-
3
-
-
0033992478
-
P53 and human cancer: The first ten thousand mutations
-
Hainaut P, Hollstein M: P53 and human cancer: The first ten thousand mutations. Adv. Cancer Res. 77, 81-137 (2000). (Pubitemid 29439303)
-
(2000)
Advances in Cancer Research
, vol.77
, pp. 81-137
-
-
Hainaut, P.1
Hollstein, M.2
-
4
-
-
0025894713
-
P53 mutations in human cancers
-
Hollstein M, Sidransky D, Vogelstein B, Harris CC: P53 mutations in human cancers. Science 253(5015), 49-53 (1991). (Pubitemid 21917115)
-
(1991)
Science
, vol.253
, Issue.5015
, pp. 49-53
-
-
Hollsteln, M.1
Sidransky, D.2
Vogelstein, B.3
Harris, C.C.4
-
5
-
-
0025853776
-
Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line
-
Fakharzadeh SS, Trusko SP, George DL: Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line. EMBRO J. 10(6), 1565-1569 (1991). (Pubitemid 21905621)
-
(1991)
EMBO Journal
, vol.10
, Issue.6
, pp. 1565-1569
-
-
Fakharzadeh, S.S.1
Trusko, S.P.2
George, D.L.3
-
6
-
-
0027325132
-
Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53
-
DOI 10.1038/362857a0
-
Oliner JD, Pietenpol JA, Thiagalingam S, Gyuris J, Kinzler KW, Vogelstein B: Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53. Nature 362(6423), 857-860 (1993). (Pubitemid 23132165)
-
(1993)
Nature
, vol.362
, Issue.6423
, pp. 857-860
-
-
Oliner, J.D.1
Pietenpol, J.A.2
Thiagalingam, S.3
Gyuris, J.4
Kinzler, K.W.5
Vogelstein, B.6
-
7
-
-
0032145989
-
The MDM2 gene amplification database
-
DOI 10.1093/nar/26.15.3453
-
Momand J, Jung D, Wilczynski S, Niland J: The MDM2 gene amplification database. Nucleic Acids Res. 26(15), 3453-3459 (1998). (Pubitemid 28347214)
-
(1998)
Nucleic Acids Research
, vol.26
, Issue.15
, pp. 3453-3459
-
-
Momand, J.1
Jung, D.2
Wilczynski, S.3
Niland, J.4
-
8
-
-
0030575937
-
Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain
-
DOI 10.1126/science.274.5289.948
-
Kussie PH, Gorina S, Marechal V et al.: Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain. Science 274(5289), 948-953 (1996). (Pubitemid 26398409)
-
(1996)
Science
, vol.274
, Issue.5289
, pp. 948-953
-
-
Kussie, P.H.1
Gorina, S.2
Marechal, V.3
Elenbaas, B.4
Moreau, J.5
Levine, A.J.6
Pavletich, N.P.7
-
9
-
-
0030905284
-
Mdm2 promotes the rapid degradation of p53
-
DOI 10.1038/387296a0
-
Haupt Y, Maya R, Kazaz A, Oren M: MDM2 promotes the rapid degradation of p53. Nature 387(6630), 296-299 (1997). n Provides information regarding the p53-MDM2 interaction and subsequent degradation of p53 following the proteasome degradation pathway. (Pubitemid 27220766)
-
(1997)
Nature
, vol.387
, Issue.6630
, pp. 296-299
-
-
Haupt, Y.1
Maya, R.2
Kazaz, A.3
Oren, M.4
-
10
-
-
0031583962
-
Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53
-
DOI 10.1016/S0014-5793(97)01480-4, PII S0014579397014804
-
Honda R, Tanaka H, Yasuda H: Oncoprotein MDM2 is a ubiquitin ligase e3 for tumor suppressor p53. FEBS Lett. 420(1), 25-27 (1997). (Pubitemid 28037193)
-
(1997)
FEBS Letters
, vol.420
, Issue.1
, pp. 25-27
-
-
Honda, R.1
Tanaka, H.2
Yasuda, H.3
-
11
-
-
0030965946
-
Regulation of p53 stability by Mdm2
-
DOI 10.1038/387299a0
-
Kubbutat MH, Jones SN, Vousden KH: Regulation of p53 stability by MDM2. Nature 387(6630), 299-303 (1997). (Pubitemid 27220767)
-
(1997)
Nature
, vol.387
, Issue.6630
, pp. 299-303
-
-
Kubbutat, M.H.G.1
Jones, S.N.2
Vousden, K.H.3
-
12
-
-
0029952441
-
In vivo ubiquitination and proteasome-mediated degradation of p53
-
Maki CG, Huibregtse JM, Howley PM: In vivo ubiquitination and proteasome-mediated degradation of p53(1). Cancer Res. 56(11), 2649-2654 (1996). (Pubitemid 26170702)
-
(1996)
Cancer Research
, vol.56
, Issue.11
, pp. 2649-2654
-
-
Maki, C.G.1
Huibregtse, J.M.2
Howley, P.M.3
-
13
-
-
0037329056
-
The p53-Mdm2 module and the ubiquitin system
-
DOI 10.1016/S1044-579X(02)00099-8, PII S1044579X02000998
-
Michael D, Oren M: The p53-MDM2 module and the ubiquitin system. Semin. Cancer Biol. 13(1), 49-58 (2003). (Pubitemid 36269180)
-
(2003)
Seminars in Cancer Biology
, vol.13
, Issue.1
, pp. 49-58
-
-
Michael, D.1
Oren, M.2
-
14
-
-
70450270900
-
Awakening guardian angels: Drugging the p53 pathway
-
Brown CJ, Lain S, Verma CS, Fersht AR, Lane DP: Awakening guardian angels: Drugging the p53 pathway. Nat. Rev. Cancer 9(12), 862-873 (2009).
-
(2009)
Nat. Rev. Cancer
, vol.9
, Issue.12
, pp. 862-873
-
-
Brown, C.J.1
Lain, S.2
Verma, C.S.3
Fersht, A.R.4
Lane, D.P.5
-
15
-
-
10744221485
-
In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
-
DOI 10.1126/science.1092472
-
Vassilev LT, Vu BT, Graves B et al.: In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science 303(5659), 844-848 (2004). nn Presents a study based on the inhibition of p53-MDM2 interaction by novel nongenotoxic drug nutlin-3a, and a new hope for cancer therapy. (Pubitemid 38174664)
-
(2004)
Science
, vol.303
, Issue.5659
, pp. 844-848
-
-
Vassilev, L.T.1
Vu, B.T.2
Graves, B.3
Carvajal, D.4
Podlaski, F.5
Filipovic, Z.6
Kong, N.7
Kammlott, U.8
Lukacs, C.9
Klein, C.10
Fotouhi, N.11
Liu, E.A.12
-
16
-
-
0033799839
-
Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs
-
Krishna R, Mayer LD: Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs. Eur. J. Pharm. Sci. 11(4), 265-283 (2000).
-
(2000)
Eur. J. Pharm. Sci.
, vol.11
, Issue.4
, pp. 265-283
-
-
Krishna, R.1
Mayer, L.D.2
-
17
-
-
58349112761
-
Reversal of p-glycoprotein-mediated multidrug resistance by the murine double minute 2 antagonist nutlin-3
-
Michaelis M, Rothweiler F, Klassert D et al.: Reversal of p-glycoprotein-mediated multidrug resistance by the murine double minute 2 antagonist nutlin-3. Cancer Res. 69(2), 416-421 (2009).
-
(2009)
Cancer Res.
, vol.69
, Issue.2
, pp. 416-421
-
-
Michaelis, M.1
Rothweiler, F.2
Klassert, D.3
-
18
-
-
0346848865
-
Nanotech approaches to drug delivery and imaging
-
DOI 10.1016/S1359-6446(03)02903-9, PII S1359644603029039
-
Sahoo SK, Labhasetwar V: Nanotech approaches to drug delivery and imaging. Drug Discov. Today 8(24), 1112-1120 (2003). (Pubitemid 37547917)
-
(2003)
Drug Discovery Today
, vol.8
, Issue.24
, pp. 1112-1120
-
-
Sahoo, S.K.1
Labhasetwar, V.2
-
19
-
-
0037462997
-
Biodegradable nanoparticles for drug and gene delivery to cells and tissue
-
DOI 10.1016/S0169-409X(02)00228-4
-
Panyam J, Labhasetwar V: Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv. Drug Deliv. Rev. 55(3), 329-347 (2003). (Pubitemid 36297053)
-
(2003)
Advanced Drug Delivery Reviews
, vol.55
, Issue.3
, pp. 329-347
-
-
Panyam, J.1
Labhasetwar, V.2
-
20
-
-
66149116471
-
Ligand-based targeted therapy for cancer tissue
-
Das M, Mohanty C, Sahoo SK: Ligand-based targeted therapy for cancer tissue. Expert Opin. Drug Deliv. 6(3), 285-304 (2009).
-
(2009)
Expert Opin. Drug Deliv.
, vol.6
, Issue.3
, pp. 285-304
-
-
Das, M.1
Mohanty, C.2
Sahoo, S.K.3
-
21
-
-
39449102666
-
Polymeric nanoparticles for cancer therapy
-
DOI 10.1080/10611860701794353, PII 790599771
-
Parveen S, Sahoo SK: Polymeric nanoparticles for cancer therapy. J. Drug Target 16(2), 108-123 (2008). (Pubitemid 351266548)
-
(2008)
Journal of Drug Targeting
, vol.16
, Issue.2
, pp. 108-123
-
-
Parveen, S.1
Sahoo, S.K.2
-
22
-
-
0036889760
-
Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway
-
DOI 10.1124/pr.54.4.561
-
Qian ZM, Li H, Sun H, Ho K: Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway. Pharmacol. Rev. 54(4), 561-587 (2002). (Pubitemid 35351196)
-
(2002)
Pharmacological Reviews
, vol.54
, Issue.4
, pp. 561-587
-
-
Qian, Z.M.1
Li, H.2
Sun, H.3
Ho, K.4
-
23
-
-
4544358907
-
Efficacy of transferrin-conjugated paclitaxel-loaded nanoparticles in a murine model of prostate cancer
-
DOI 10.1002/ijc.20405
-
Sahoo SK, Ma W, Labhasetwar V: Efficacy of transferrin-conjugated paclitaxel-loaded nanoparticles in a murine model of prostate cancer. Int. J. Cancer 112(2), 335-340 (2004). nn Demonstrates how a simple molecule transferrin can be used as a potent targeting agent to enhance the therapeutic efficacy of many neoplastic drugs. (Pubitemid 39244375)
-
(2004)
International Journal of Cancer
, vol.112
, Issue.2
, pp. 335-340
-
-
Sahoo, S.K.1
Ma, W.2
Labhasetwar, V.3
-
24
-
-
68749092564
-
Targeted epidermal growth factor receptor nanoparticle bioconjugates for breast cancer therapy
-
Acharya S, Dilnawaz F, Sahoo SK: Targeted epidermal growth factor receptor nanoparticle bioconjugates for breast cancer therapy. Biomaterials 30(29), 5737-5750 (2009).
-
(2009)
Biomaterials
, vol.30
, Issue.29
, pp. 5737-5750
-
-
Acharya, S.1
Dilnawaz, F.2
Sahoo, S.K.3
-
25
-
-
0042634190
-
Fluorescence and electron microscopy probes for cellular and tissue uptake of poly(D,L-lactide-co-glycolide) nanoparticles
-
DOI 10.1016/S0378-5173(03)00295-3
-
Panyam J, Sahoo SK, Prabha S, Bargar T, Labhasetwar V: Fluorescence and electron microscopy probes for cellular and tissue uptake of poly(d,l-lactide-co-glycolide) nanoparticles. Int. J. Pharm. 262(1-2), 1-11 (2003). (Pubitemid 36966688)
-
(2003)
International Journal of Pharmaceutics
, vol.262
, Issue.1-2
, pp. 1-11
-
-
Panyam, J.1
Sahoo, S.K.2
Prabha, S.3
Bargar, T.4
Labhasetwar, V.5
-
26
-
-
24144490885
-
Enhanced antiproliferative activity of transferrin-conjugated paclitaxel-loaded nanoparticles is mediated via sustained intracellular drug retention
-
DOI 10.1021/mp050032z
-
Sahoo SK, Labhasetwar V: Enhanced antiproliferative activity of transferrin-conjugated paclitaxel-loaded nanoparticles is mediated via sustained intracellular drug retention. Mol. Pharm. 2(5), 373-383 (2005). (Pubitemid 41503678)
-
(2005)
Molecular Pharmaceutics
, vol.2
, Issue.5
, pp. 373-383
-
-
Sahoo, S.K.1
Labhasetwar, V.2
-
27
-
-
51849085687
-
The intracellular uptake ability of chitosan-coated poly (d,l-lactide-co-glycolide) nanoparticles
-
Kim BS, Kim CS, Lee KM: The intracellular uptake ability of chitosan-coated poly (d,l-lactide-co-glycolide) nanoparticles. Arch. Pharm. Res. 31(8), 1050-1054 (2008).
-
(2008)
Arch. Pharm. Res.
, vol.31
, Issue.8
, pp. 1050-1054
-
-
Kim, B.S.1
Kim, C.S.2
Lee, K.M.3
-
28
-
-
48349102690
-
Magnetic nanoparticles with dual functional properties: Drug delivery and magnetic resonance imaging
-
Jain TK, Richey J, Strand M, Leslie-Pelecky DL, Flask CA, Labhasetwar V: Magnetic nanoparticles with dual functional properties: Drug delivery and magnetic resonance imaging. Biomaterials 29(29), 4012-4021 (2008).
-
(2008)
Biomaterials
, vol.29
, Issue.29
, pp. 4012-4021
-
-
Jain, T.K.1
Richey, J.2
Strand, M.3
Leslie-Pelecky, D.L.4
Flask, C.A.5
Labhasetwar, V.6
-
29
-
-
33750346173
-
Small-molecule MDM2 antagonists as a new therapy concept for neuroblastoma
-
DOI 10.1158/0008-5472.CAN-06-0792
-
Van Maerken T, Speleman F, Vermeulen J et al.: Small-molecule MDM2 antagonists as a new therapy concept for neuroblastoma. Cancer Res. 66(19), 9646-9655 (2006). (Pubitemid 44623664)
-
(2006)
Cancer Research
, vol.66
, Issue.19
, pp. 9646-9655
-
-
Van Maerken, T.1
Speleman, F.2
Vermeulen, J.3
Lambertz, I.4
De Clercq, S.5
De Smet, E.6
Yigit, N.7
Coppens, V.8
Philippe, J.9
De Paepe, A.10
Marine, J.-C.11
Vandesompele, J.12
-
30
-
-
3042613166
-
Sustained cytoplasmic delivery of drugs with intracellular receptors using biodegradable nanoparticles
-
Panyam J, Labhasetwar V: Sustained cytoplasmic delivery of drugs with intracellular receptors using biodegradable nanoparticles. Mol. Pharm. 1(1), 77-84 (2004).
-
(2004)
Mol. Pharm.
, vol.1
, Issue.1
, pp. 77-84
-
-
Panyam, J.1
Labhasetwar, V.2
-
31
-
-
33746118057
-
Activation of mammalian target of rapamycin signaling pathway contributes to tumor cell survival in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma
-
DOI 10.1158/0008-5472.CAN-05-3018
-
Vega F, Medeiros LJ, Leventaki V et al.: Activation of mammalian target of rapamycin signaling pathway contributes to tumor cell survival in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma. Cancer Res. 66(13), 6589-6597 (2006). (Pubitemid 44085614)
-
(2006)
Cancer Research
, vol.66
, Issue.13
, pp. 6589-6597
-
-
Vega, F.1
Medeiros, L.J.2
Leventaki, V.3
Atwell, C.4
Cho-Vega, J.H.5
Tian, L.6
Claret, F.-X.7
Rassidakis, G.Z.8
-
32
-
-
34249894977
-
Targeting cancer cells using PLGA nanoparticles surface modified with monoclonal antibody
-
DOI 10.1016/j.jconrel.2007.03.012, PII S0168365907001472
-
Kocbek P, Obermajer N, Cegnar M, Kos J, Kristl J: Targeting cancer cells using plga nanoparticles surface modified with monoclonal antibody. J. Control Release 120(1-2), 18-26 (2007). (Pubitemid 46874614)
-
(2007)
Journal of Controlled Release
, vol.120
, Issue.1-2
, pp. 18-26
-
-
Kocbek, P.1
Obermajer, N.2
Cegnar, M.3
Kos, J.4
Kristl, J.5
-
33
-
-
0036955764
-
Intracellular drug delivery using poly(D,L-lactide-co-glycolide) nano-particles derivatized with a peptide from a transcriptional activator protein of HIV-1
-
DOI 10.1023/A:1021373731787
-
Nam YS, Park JY, Han SH, Chang IS: Intracellular drug delivery using poly(d,l-lactide-co-glycolide) nanoparticles derivatized with a peptide from a transcriptional activator protein of HIV-1. Biotechnology Lett. 24, 2093-2098 (2002). (Pubitemid 36093404)
-
(2002)
Biotechnology Letters
, vol.24
, Issue.24
, pp. 2093-2098
-
-
Nam, Y.S.1
Park, J.Y.2
Han, S.-H.3
Chang, I.-S.4
-
34
-
-
0037026269
-
Size-dependency of nanoparticle-mediated gene transfection: Studies with fractionated nanoparticles
-
DOI 10.1016/S0378-5173(02)00315-0, PII S0378517302003150
-
Prabha S, Zhou WZ, Panyam J, Labhasetwar V: Size-dependency of nanoparticle-mediated gene transfection: Studies with fractionated nanoparticles. Int. J. Pharm. 244(1-2), 105-115 (2002). (Pubitemid 35245451)
-
(2002)
International Journal of Pharmaceutics
, vol.244
, Issue.1-2
, pp. 105-115
-
-
Prabha, S.1
Zhou, W.-Z.2
Panyam, J.3
Labhasetwar, V.4
-
35
-
-
68249134353
-
Sustained antibacterial activity of doxycycline-loaded poly(d,l-lactide-co-glycolide) and poly(e-caprolactone) nanoparticles
-
Misra R, Acharya S, Dilnawaz F, Sahoo SK: Sustained antibacterial activity of doxycycline-loaded poly(d,l-lactide-co-glycolide) and poly(e-caprolactone) nanoparticles. Nanomedicine (Lond). 4(5), 519-530 (2009).
-
(2009)
Nanomedicine (Lond).
, vol.4
, Issue.5
, pp. 519-530
-
-
Misra, R.1
Acharya, S.2
Dilnawaz, F.3
Sahoo, S.K.4
-
36
-
-
67650090674
-
The in vitro sub-cellular localization and in vivo efficacy of novel chitosan/GMO nanostructures containing paclitaxel
-
Trickler WJ, Nagvekar AA, Dash AK: The in vitro sub-cellular localization and in vivo efficacy of novel chitosan/GMO nanostructures containing paclitaxel. Pharm. Res. 26(8), 1963-1973 (2009).
-
(2009)
Pharm. Res.
, vol.26
, Issue.8
, pp. 1963-1973
-
-
Trickler, W.J.1
Nagvekar, A.A.2
Dash, A.K.3
-
37
-
-
0037331856
-
Dynamics of endocytosis and exocytosis of poly(D,L-lactide-co-glycolide) nanoparticles in vascular smooth muscle cells
-
DOI 10.1023/A:1022219003551
-
Panyam J, Labhasetwar V: Dynamics of endocytosis and exocytosis of poly(d,l-lactide-co-glycolide) nanoparticles in vascular smooth muscle cells. Pharm. Res. 20(2), 212-220 (2003). (Pubitemid 36277684)
-
(2003)
Pharmaceutical Research
, vol.20
, Issue.2
, pp. 212-220
-
-
Panyam, J.1
Labhasetwar, V.2
-
38
-
-
28844485350
-
Expression of pro-apoptotic (p53, p21, bax, bak and fas) and anti-apoptotic (bcl-2 and bcl-x) proteins in serous versus mucinous borderline ovarian tumours
-
DOI 10.1002/jso.20424
-
Fauvet R, Dufournet C, Poncelet C, Uzan C, Hugol D, Darai E: Expression of pro-apoptotic (p53, p21, bax, bak and fas) and anti-apoptotic (bcl-2 and bcl-x) proteins in serous versus mucinous borderline ovarian tumours. J. Surg. Oncol. 92(4), 337-343 (2005). (Pubitemid 41779293)
-
(2005)
Journal of Surgical Oncology
, vol.92
, Issue.4
, pp. 337-343
-
-
Fauvet, R.1
Dufournet, C.2
Poncelet, C.3
Uzan, C.4
Hugol, D.5
Darai, E.6
-
39
-
-
22244443786
-
P53 activation by small molecules: Application in oncology
-
DOI 10.1021/jm058174k
-
Vassilev LT: P53 activation by small molecules: Application in oncology. J. Med. Chem. 48(14), 4491-4499 (2005). (Pubitemid 40993409)
-
(2005)
Journal of Medicinal Chemistry
, vol.48
, Issue.14
, pp. 4491-4499
-
-
Vassilev, L.T.1
-
40
-
-
67449164584
-
Restoration of p53 pathway by nutlin-3 induces cell cycle arrest and apoptosis in human rhabdomyosarcoma cells
-
Miyachi M, Kakazu N, Yagyu S et al.: Restoration of p53 pathway by nutlin-3 induces cell cycle arrest and apoptosis in human rhabdomyosarcoma cells. Clin. Cancer Res. 15(12), 4077-4084 (2009).
-
(2009)
Clin. Cancer Res.
, vol.15
, Issue.12
, pp. 4077-4084
-
-
Miyachi, M.1
Kakazu, N.2
Yagyu, S.3
-
41
-
-
0027989808
-
Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis
-
Koopman G, Reutelingsperger CP, Kuijten GA, Keehnen RM, Pals ST, van Oers MH: Annexin v for flow cytometric detection of phosphatidylserine expression on b cells undergoing apoptosis. Blood 84(5), 1415-1420 (1994). (Pubitemid 24273007)
-
(1994)
Blood
, vol.84
, Issue.5
, pp. 1415-1420
-
-
Koopman, G.1
Reutelingsperger, C.P.M.2
Kuijten, G.A.M.3
Keehnen, R.M.J.4
Pals, S.T.5
Van Oers, M.H.J.6
-
42
-
-
0030941458
-
P53, the cellular gatekeeper for growth and division
-
DOI 10.1016/S0092-8674(00)81871-1
-
Levine AJ: P53, the cellular gatekeeper for growth and division. Cell 88(3), 323-331 (1997). (Pubitemid 27131374)
-
(1997)
Cell
, vol.88
, Issue.3
, pp. 323-331
-
-
Levine, A.J.1
-
43
-
-
11144224782
-
Phosphorylation of p53 on key serines is dispensable for transcriptional activation and apoptosis
-
DOI 10.1074/jbc.M410233200
-
Thompson T, Tovar C, Yang H et al.: Phosphorylation of p53 on key serines is dispensable for transcriptional activation and apoptosis. J. Biol. Chem. 279(51), 53015-53022 (2004). (Pubitemid 40051800)
-
(2004)
Journal of Biological Chemistry
, vol.279
, Issue.51
, pp. 53015-53022
-
-
Thompson, T.1
Tovar, C.2
Yang, H.3
Carvajal, D.4
Vu, B.T.5
Xu, Q.6
Wahl, G.M.7
Heimbrook, D.C.8
Vassilev, L.T.9
-
44
-
-
0035862692
-
Taxane-antibody conjugates afford potent cytotoxicity, enhanced solubility, and tumor target selectivity
-
Guillemard V, Saragovi HU: Taxane-antibody conjugates afford potent cytotoxicity, enhanced solubility, and tumor target selectivity. Cancer Res. 61(2), 694-699 (2001). (Pubitemid 32140477)
-
(2001)
Cancer Research
, vol.61
, Issue.2
, pp. 694-699
-
-
Guillemard, V.1
Saragovi, H.U.2
-
45
-
-
0037947564
-
Immunomicelles: Targeted pharmaceutical carriers for poorly soluble drugs
-
DOI 10.1073/pnas.0931428100
-
Torchilin VP, Lukyanov AN, Gao Z, Papahadjopoulos-Sternberg B: Immunomicelles: Targeted pharmaceutical carriers for poorly soluble drugs. Proc. Natl Acad. Sci. USA 100(10), 6039-6044 (2003). nn Depicts the role of targeted nanocarriers in enhancing the therapeutic efficiency of conventional drugs. (Pubitemid 36576927)
-
(2003)
Proceedings of the National Academy of Sciences of the United States of America
, vol.100
, Issue.10
, pp. 6039-6044
-
-
Torchilin, V.P.1
Lukyanov, A.N.2
Gao, Z.3
Papahadjopoulos-Sternberg, B.4
-
46
-
-
1842865327
-
Section 5. Breast: Sentinel lymph node biopsy in breast cancer using technetium-99m tin colloids of different sizes
-
PII S0753332202002226
-
Jinno H, Ikeda T, Matsui A et al.: Sentinel lymph node biopsy in breast cancer using technetium-99m tin colloids of different sizes. Biomed. Pharmacother. 56(Suppl. 1), 213S-216S (2002). (Pubitemid 35448049)
-
(2002)
Biomedicine and Pharmacotherapy
, vol.56
, Issue.SUPPL. 1
-
-
Jinno, H.1
Ikeda, T.2
Matsui, A.3
Kitagawa, Y.4
Kitajima, M.5
Fujii, H.6
Nakamura, K.7
Kubo, A.8
-
47
-
-
0035755278
-
Resistant mechanisms of anthracyclines - pirarubicin might partly break through the p-glycoprotein-mediated drug-resistance of human breast cancer tissues
-
Kubota T, Furukawa T, Tanino H et al.: Resistant mechanisms of anthracyclines - pirarubicin might partly break through the p-glycoprotein- mediated drug-resistance of human breast cancer tissues. Breast Cancer 8(4), 333-338 (2001).
-
(2001)
Breast Cancer
, vol.8
, Issue.4
, pp. 333-338
-
-
Kubota, T.1
Furukawa, T.2
Tanino, H.3
-
48
-
-
0346670126
-
Clathrin and caveolin-1 expression in primary pigmented rabbit conjunctival epithelial cells: Role in PLGA nanoparticle endocytosis
-
Qaddoumi MG, Gukasyan HJ, Davda J, Labhasetwar V, Kim KJ, Lee VH: Clathrin and caveolin-1 expression in primary pigmented rabbit conjunctival epithelial cells: Role in PLGA nanoparticle endocytosis. Mol. Vis. 9, 559-568 (2003). (Pubitemid 38097623)
-
(2003)
Molecular Vision
, vol.9
, pp. 559-568
-
-
Qaddoumi, M.G.1
Gukasyan, H.J.2
Davda, J.3
Labhasetwar, V.4
Kim, K.-J.5
Lee, V.H.L.6
-
49
-
-
0036324712
-
Rapid endo-lysosomal escape of poly(DL-lactide-co-glycolide) nanoparticles: Implications for drug and gene delivery
-
DOI 10.1096/fj.02-0088com
-
Panyam J, Zhou WZ, Prabha S, Sahoo SK, Labhasetwar V: Rapid endo-lysosomal escape of poly(dl-lactide-co-glycolide) nanoparticles: Implications for drug and gene delivery. FASEB J. 16(10), 1217-1226 (2002). (Pubitemid 34815409)
-
(2002)
FASEB Journal
, vol.16
, Issue.10
, pp. 1217-1226
-
-
Panyam, J.1
Zhou, W.-Z.2
Prabha, S.3
Sahoo, S.K.4
Labhasetwar, V.5
-
50
-
-
27744508956
-
Paclitaxel-loaded PLGA nanoparticles: Potentiation of anticancer activity by surface conjugation with wheat germ agglutinin
-
DOI 10.1016/j.jconrel.2005.08.013, PII S0168365905003664
-
Mo Y, Lim LY: Paclitaxel-loaded PLGA nanoparticles: Potentiation of anticancer activity by surface conjugation with wheat germ agglutinin. J. Control Release 108(2-3), 244-262 (2005). (Pubitemid 41608658)
-
(2005)
Journal of Controlled Release
, vol.108
, Issue.2-3
, pp. 244-262
-
-
Mo, Y.1
Lim, L.-Y.2
-
51
-
-
0027496935
-
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin- dependent kinases
-
DOI 10.1016/0092-8674(93)90499-G
-
Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ: The p21 CDK-interacting protein CIP1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75(4), 805-816 (1993). (Pubitemid 23346377)
-
(1993)
Cell
, vol.75
, Issue.4
, pp. 805-816
-
-
Harper, J.W.1
Adami, G.R.2
Wei, N.3
Keyomarsi, K.4
Elledge, S.J.5
-
52
-
-
0028931265
-
Principles of CDK regulation
-
Morgan DO: Principles of CDK regulation. Nature 374(6518), 131-134 (1995).
-
(1995)
Nature
, vol.374
, Issue.6518
, pp. 131-134
-
-
Morgan, D.O.1
-
53
-
-
0029033861
-
The retinoblastoma protein and cell cycle control
-
Weinberg RA: The retinoblastoma protein and cell cycle control. Cell 81(3), 323-330 (1995).
-
(1995)
Cell
, vol.81
, Issue.3
, pp. 323-330
-
-
Weinberg, R.A.1
-
54
-
-
0027717617
-
P21 is a universal inhibitor of cyclin kinases
-
DOI 10.1038/366701a0
-
Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D: P21 is a universal inhibitor of cyclin kinases. Nature 366(6456), 701-704 (1993). (Pubitemid 24036020)
-
(1993)
Nature
, vol.366
, Issue.6456
, pp. 701-704
-
-
Xiong, Y.1
Hannon, G.J.2
Zhang, H.3
Casso, D.4
Kobayashi, R.5
Beach, D.6
-
55
-
-
68749114554
-
Inhibition of apoptosis through localized delivery of rapamycin-loaded nanoparticles prevented neointimal hyperplasia and reendothelialized injured
-
Reddy MK, Vasir JK, Sahoo SK, Jain TK, Yallapu MM, Labhasetwar V: Inhibition of apoptosis through localized delivery of rapamycin-loaded nanoparticles prevented neointimal hyperplasia and reendothelialized injured. Circ. Cardiovasc. Intervent. 1, 209-216 (2008).
-
(2008)
Circ. Cardiovasc. Intervent.
, vol.1
, pp. 209-216
-
-
Reddy, M.K.1
Vasir, J.K.2
Sahoo, S.K.3
Jain, T.K.4
Yallapu, M.M.5
Labhasetwar, V.6
-
56
-
-
32444449180
-
Small-molecule MDM2 antagonists reveal aberrant p53 signaling in cancer: Implications for therapy
-
DOI 10.1073/pnas.0507493103
-
Tovar C, Rosinski J, Filipovic Z et al.: Small-molecule MDM2 antagonists reveal aberrant p53 signaling in cancer: Implications for therapy. Proc. Natl Acad. Sci. USA 103(6), 1888-1893 (2006). (Pubitemid 43228788)
-
(2006)
Proceedings of the National Academy of Sciences of the United States of America
, vol.103
, Issue.6
, pp. 1888-1893
-
-
Tovar, C.1
Rosinski, J.2
Filipovic, Z.3
Higgins, B.4
Kolinsky, K.5
Hilton, H.6
Zhao, X.7
Vu, B.T.8
Qing, W.9
Packman, K.10
Myklebost, O.11
Heimbrook, D.C.12
Vassilev, L.T.13
|